Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Chubb
AstraZeneca
Teva
UBS
Mallinckrodt
Federal Trade Commission
Fish and Richardson

Generated: September 26, 2018

DrugPatentWatch Database Preview

METHYSERGIDE MALEATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for methysergide maleate and what is the scope of methysergide maleate patent protection?

Methysergide maleate is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for METHYSERGIDE MALEATE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 21
Patent Applications: 1
DailyMed Link:METHYSERGIDE MALEATE at DailyMed
Medical Subject Heading (MeSH) Categories for METHYSERGIDE MALEATE
Synonyms for METHYSERGIDE MALEATE
(+)-N-((1-Hydroxymethyl)propyl)-1-methyl-D-lysergamide bimaleate
(2Z)-BUT-2-ENEDIOIC ACID; (4R,7R)-N-[(2S)-1-HYDROXYBUTAN-2-YL]-6,11-DIMETHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2,9,12,14-PENTAENE-4-CARBOXAMIDE
[8?(S)]-9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide maleate
[8beta(S)]-9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide maleate
1-(Hydroxymethyl)propylamide of 1-methyl-(+)-lysergic acid hydrogen maleate
1-Methyl-D-lysergic acid butanolamide dimaleate
1257-58-5
129-49-7
29605-96-7
2U7H1466GH
32537-90-9
52502-68-8
87387-76-6
9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide maleate (1:1) (salt)
AKOS024456362
AN-23038
C21H28N3O2.C4H3O4
C25H31N3O6
CCG-213467
CHEBI:6894
CHEMBL1200938
D00681
Deseril-retard
Desernil bismaleate
EINECS 204-950-9
Ergoline-8-beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, maleate (1:1) (salt)
Ergoline-8-beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-,maleate (1:1) (salt)
Ergoline-8-carboxamide, 9,10-didehydro-N-((1S)-1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-, (2Z)-2-butenedioate (1:1) (salt)
Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-, (Z)-2-butenedioate (1:1) (salt)
Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1- (hydroxymethyl)propyl]-1,6-dimethyl-, (8ss)-, (2Z)-2-butenedioate (1:1) (salt)
Ergoline-8beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, maleate (1:2) (salt)
Ergoline-8beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, maleate (1:2) (salt) (8CI)
EU-0100863
HMS2093N13
HMS2231L15
HMS3262N07
LP00863
LS-64362
LWYXFDXUMVEZKS-ZVFOLQIPSA-N
Lysergamide, N-((1-hydroxymethyl)propyl)-1-methyl-, maleate
M-137
Methysergide bimaleate
Methysergide dimaleate
Methysergide hydrogen maleate
Methysergide maleate (USP)
Methysergide maleate [USAN]
Methysergide maleate salt
Methysergide maleate salt, solid
Methysergide maleate, United States Pharmacopeia (USP) Reference Standard
MFCD00083185
MLS000069364
MLS001076153
MolPort-003-958-638
NCGC00261548-01
NSC 186061
NSC-759143
NSC759143
Pharmakon1600-01505492
PL009422
regid855989
Sansert (TN)
SMR000058483
SMR000653472
Tox21_500863
UNII-2U7H1466GH

US Patents and Regulatory Information for METHYSERGIDE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis SANSERT methysergide maleate TABLET;ORAL 012516-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Chubb
AstraZeneca
Teva
UBS
Mallinckrodt
Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.